Source 1primary paper2025MED
Toolkit/microfluidics
microfluidics
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
The review integrates data from in vitro, in silico, and clinical studies, including both classical detection strategies and emerging technologies such as clustered regularly interspaced short palindromic repeats (CRISPR)-based modulation, biosensors, and microfluidics.
Usefulness & Problems
Why this is useful
Microfluidics is named as an emerging technology integrated with genetic engineering approaches in tissue engineering. The review places it within the set of tools that expand complex tissue fabrication.; integration with genetic engineering in tissue engineering; complex tissue fabrication; Microfluidics is presented as an emerging technology included in the review's discussion of efflux-related detection methods. The abstract groups it with novel technologies that improve precision.; efflux detection; molecular detection; Microfluidics provides device-based control and integration for engineered organoid systems. In the supplied summary, it is a central engineering approach associated with organoids-on-chip.; integrating engineering control into organoid systems
Source:
Microfluidics is named as an emerging technology integrated with genetic engineering approaches in tissue engineering. The review places it within the set of tools that expand complex tissue fabrication.
Source:
integration with genetic engineering in tissue engineering
Source:
complex tissue fabrication
Source:
Microfluidics is presented as an emerging technology included in the review's discussion of efflux-related detection methods. The abstract groups it with novel technologies that improve precision.
Source:
efflux detection
Source:
molecular detection
Source:
Microfluidics provides device-based control and integration for engineered organoid systems. In the supplied summary, it is a central engineering approach associated with organoids-on-chip.
Source:
integrating engineering control into organoid systems
Problem solved
It is presented as part of the enabling technology stack for more advanced tissue fabrication workflows.; contributes to expanded complex tissue fabrication workflows; It is positioned as part of the move beyond classical efflux detection methods that have technical limitations.; providing newer detection technologies with improved precision relative to classical methods; The approach is presented as part of the engineering toolkit for improving organoid utility and control. It supports the review's broader focus on translationally useful organoid systems.; provides microfluidic integration for organoid engineering
Source:
It is presented as part of the enabling technology stack for more advanced tissue fabrication workflows.
Source:
contributes to expanded complex tissue fabrication workflows
Source:
It is positioned as part of the move beyond classical efflux detection methods that have technical limitations.
Source:
providing newer detection technologies with improved precision relative to classical methods
Source:
The approach is presented as part of the engineering toolkit for improving organoid utility and control. It supports the review's broader focus on translationally useful organoid systems.
Source:
provides microfluidic integration for organoid engineering
Problem links
The gap explicitly calls for better datasets and controlled ecosystem testbeds, and microfluidics is an actionable platform method for building controlled experimental environments and integrated detection workflows. It could plausibly support small-scale, high-throughput studies of microbial or tissue-like ecological interactions relevant to closed ecosystem experiments.
Under-Provisioning of Antibiotics, Vaccines and Other Interventions for Major Global Health Challenges
Gap mapView gapMicrofluidics is a plausible enabling assay/platform technology for faster screening or detection workflows, which could modestly support intervention development pipelines. However, the supplied summary does not directly connect it to vaccines, therapeutics, or malnutrition interventions.
contributes to expanded complex tissue fabrication workflows
LiteratureIt is presented as part of the enabling technology stack for more advanced tissue fabrication workflows.
Source:
It is presented as part of the enabling technology stack for more advanced tissue fabrication workflows.
provides microfluidic integration for organoid engineering
LiteratureThe approach is presented as part of the engineering toolkit for improving organoid utility and control. It supports the review's broader focus on translationally useful organoid systems.
Source:
The approach is presented as part of the engineering toolkit for improving organoid utility and control. It supports the review's broader focus on translationally useful organoid systems.
providing newer detection technologies with improved precision relative to classical methods
LiteratureIt is positioned as part of the move beyond classical efflux detection methods that have technical limitations.
Source:
It is positioned as part of the move beyond classical efflux detection methods that have technical limitations.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
device-level integration of organoid-on-chip culture systemsmicrofluidic flow-based environmental controlTarget processes
editingselectionImplementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: payload burdenoperating role: sensor
used as part of integrated tissue engineering platforms; Use requires microfluidic hardware and compatibility with organoid culture workflows. The payload does not specify exact chip designs or flow conditions.; requires microfluidic device infrastructure
The abstract does not provide specific claims about what microfluidics alone can or cannot achieve.; the abstract does not specify microfluidics-specific strengths or weaknesses
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Source 2review2021Nature Reviews Materials
Source 3review2025MED
Ranked Claims
The review identifies long-term genetic stability, scalability, and off-target effects as challenges for genetically engineered tissues.
We address the field's challenges, including long-term genetic stability, scalability, and off-target effects, while also considering the ethical implications and evolving regulatory landscape of genetically engineered tissues.
The review describes base editing and synthetic genetic circuits as emerging technologies explored for creating smart tissues capable of dynamic environmental responses.
Emerging technologies in genetic engineering, including base editing and synthetic genetic circuits, have been explored for their potential to create "smart" tissues capable of dynamic environmental responses.
The review states that integrating genetic engineering with 3D-bioprinting, microfluidics, and smart biomaterials expands the horizons of complex tissue fabrication.
We further investigate the integration of these genetic approaches with emerging technologies such as 3D-bioprinting, microfluidics, and smart biomaterials, which collectively expand the horizons of complex tissue fabrication.
Classical efflux detection methods such as MIC shifts with inhibitors and fluorometric assays have technical limitations, whereas novel technologies offer improved precision.
Classical methods for detecting efflux (e.g. minimum inhibitory concentration (MIC) shifts with inhibitors, fluorometric assays) have technical limitations, while novel technologies offer improved precision.
The review examines CRISPR-Cas9, TALENs, and synthetic biology as genetic engineering approaches for modifying cellular behaviors and functions in tissue engineering.
We critically examine the application of advanced genetic engineering techniques, including CRISPR-Cas9, TALENs, and synthetic biology, in modifying cellular behaviors and functions for tissue engineering.
Organoid-on-chip and microfluidic integration are major engineering themes linked to this review topic.
Vascularization strategies are major engineering themes linked to this review topic and are associated with improving organoid maturity and function.
Approval Evidence
3 sources3 linked approval claimsfirst-pass slug microfluidics
The review integrates data from in vitro, in silico, and clinical studies, including both classical detection strategies and emerging technologies such as clustered regularly interspaced short palindromic repeats (CRISPR)-based modulation, biosensors, and microfluidics.
Source:
We further investigate the integration of these genetic approaches with emerging technologies such as 3D-bioprinting, microfluidics, and smart biomaterials, which collectively expand the horizons of complex tissue fabrication.
Source:
The supplied web research summary states that organoid-on-chip and microfluidic integration are strongly supported enrichment themes repeatedly linked to this review topic, and explicitly lists microfluidics as a related item candidate.
Source:
integration summarysupports
The review states that integrating genetic engineering with 3D-bioprinting, microfluidics, and smart biomaterials expands the horizons of complex tissue fabrication.
We further investigate the integration of these genetic approaches with emerging technologies such as 3D-bioprinting, microfluidics, and smart biomaterials, which collectively expand the horizons of complex tissue fabrication.
Source:
method limitationsupports
Classical efflux detection methods such as MIC shifts with inhibitors and fluorometric assays have technical limitations, whereas novel technologies offer improved precision.
Classical methods for detecting efflux (e.g. minimum inhibitory concentration (MIC) shifts with inhibitors, fluorometric assays) have technical limitations, while novel technologies offer improved precision.
Source:
theme summarysupports
Organoid-on-chip and microfluidic integration are major engineering themes linked to this review topic.
Source:
Comparisons
Source-stated alternatives
The abstract groups microfluidics with 3D-bioprinting and smart biomaterials as adjacent convergent technologies.; The supplied summary contrasts microfluidic integration with engineered matrices, geometry control approaches, and vascularization strategies.
Source:
The abstract groups microfluidics with 3D-bioprinting and smart biomaterials as adjacent convergent technologies.
Source:
The supplied summary contrasts microfluidic integration with engineered matrices, geometry control approaches, and vascularization strategies.
Source-backed strengths
presented as an emerging enabling technology in the tissue engineering toolkit; novel technologies offer improved precision
Source:
presented as an emerging enabling technology in the tissue engineering toolkit
Source:
novel technologies offer improved precision
Compared with high throughput screening
microfluidics and high throughput screening address a similar problem space because they share editing, selection.
Shared frame: same top-level item type; shared target processes: editing, selection
Compared with single-cell RNA sequencing
microfluidics and single-cell RNA sequencing address a similar problem space because they share editing, selection.
Shared frame: same top-level item type; shared target processes: editing, selection
Relative tradeoffs: appears more independently replicated; looks easier to implement in practice.
Compared with spatial transcriptomics
microfluidics and spatial transcriptomics address a similar problem space because they share editing, selection.
Shared frame: same top-level item type; shared target processes: editing, selection
Relative tradeoffs: appears more independently replicated.
Ranked Citations
- 1.
- 2.
- 3.